Results

Total Results: 3,717 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

2061. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
      March 22, 2023 - Similarly, we would consider including a study of occupational or other therapies as an adjunct treatment … , interpersonal psychotherapy, psychodynamic therapy, dialectical behavior therapy, equine- assisted … Adverse effects/harms: - Metabolic effects: weight gain, hyperglycemia and diabetes, hyperlipidemia … history (e.g., previous psychosocial and pharmacologic treatments, whether or not treatments are ongoing … " or "multidimensional treatment" or "multisystemic therapy" or "multi-systemic therapy" or "negative

2062. CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
      April 23, 2019 - Since there are no FDA approved treatments within the anti-sclerostin monoclonal antibody class, Amgen … vertebral fracture.2,4,6 Therefore, w hile drug holidays may be an option for certain osteoporosis therapies … Lancet Diabetes Endocrinol 2017;5:513-523. … While drug holidays may be an option for certain therapies, DMB should not be discontinued without … Given that there are no other treatments within the anti-sclerostin monoclonal antibody class, this

2063. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
      September 06, 2016 - For each included study, one investigator extracted information about design, population, tests or treatments … The combination therapy was found to be noninferior to isoniazid-only treatment. … Limited usefulness of QuantiFERON-TB Gold In-Tube for monitoring anti-tuberculosis therapy. … The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis

2064. Care Coordination Quality Measure for Primary Care (CCQM-PC) (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/improve/coordination/ccqmpc/cati-script.pdf
      July 01, 2016 - or other primary care professionals in this office know about your past health problems or past treatments … healthcare (e.g., flu shot), medicine, surgery, or other treatment. … Professional treatment refers to any treatment supervised by a health professional. 1 YES, I have … received professional treatment for this condition 2 NO, I have NOT received professional treatment … Diabetes? 66k. Osteoporosis? 66l. Skin cancer? 66m. Any other kind of cancer? 66n.

2065. Meditation Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
      January 01, 2014 - Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … • Therapeutic touch • Eye movement desensitization reprocessing • Relaxation therapy • Spiritual therapy … In each comparison against a known treatment or therapy, mindfulness did not outperform the control … B2) and indicated that meditative therapies were no better than the 13 specific therapies they … among adults with type 2 diabetes: a pilot study.

2066. References (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-131-references.pdf
      October 23, 2013 - costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment … Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length … Decreasing hospital length of stay for bronchiolitis by using an observation unit and home oxygen therapy … New bundled world: quality of care and readmission in diabetes patients. … J Diabetes Sci Technol. 2012;6(3):563–571. 76.

2067. Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication
      April 26, 2022 - include the risk factors of age, cholesterol levels, systolic blood pressure level, antihypertension treatment … underprediction in disadvantaged communities 8 , 9 that could lead to underutilization of preventive therapies … risk factors should be considered in the overall decision about whether to start or continue aspirin therapy … Treatment or Intervention The benefits of aspirin for CVD prevention appear similar for a low dose … Association of aspirin use with major bleeding in patients with and without diabetes.

2068. Psn-Pdf (pdf file)
      psnet.ahrq.gov/node/49718/psn-pdf
      January 01, 2015 - with comorbidities that included coronary artery disease and a prior bypass graft, insulin-dependent diabetes … Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve … physician compliance with published therapy guidelines. … Therapeutic approach to hypokalemia. Nephron. 2002;92(suppl 1):28-32. [go to PubMed] 10. … potassium concentration Preparation of potassium salts Potassium chloride: most effective and first line treatment

2069. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
      May 01, 2012 - treatments). … , including the expected beneficial therapeutic effect as well as adverse effects of the treatment. … of adherence to prior therapies, particularly if adherence to therapy can affect the safety or effectiveness … Since they are not in fact candidates for one of the treatments, comparisons of treatment effectiveness … Clinical Pharmacology & Therapeutics 2004;75:234–241.

2070. Microsoft Word - QDR 2014 HCUP Short Methods Report_041015_FINAL.docx (pdf file)
      hcup-us.ahrq.gov/reports/methods/2015_02.pdf
      January 01, 2015 - seven key areas of health care: patient safety, person-centered care, care coordination, effective treatment … services, medical practice patterns, patient safety, access to health care programs, and outcomes of treatments … are long-term non-acute care hospitals, psychiatric hospitals, and alcoholism/chemical dependency treatment … FAILURE W CC 296,495 0.8 296,685 0.8 897: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY … DISORDERS W/O MCC 399,251 1.0 392,626 1.0 897: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY

2071. Improving Diagnosis of Hypertension in Children - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r21hs024100-rao-final-report-2018.pdf
      January 01, 2018 - increased risk for adult hypertension as well as target organ damage in childhood which responds to timely treatment … , the established impact during childhood provides a compelling rationale for timely diagnosis and treatment … Control (n=1725) IDHC (n=1721) P-value Diabetes … Control (n=1794) IDHC (n=1402) P-value Diabetes … Expanding access to hepatitis C virus treatment – Extension for community healthcare outcomes (ECHO)

2072. PATIENT INFORMED CONSENT ANDAUTHORIZATION FOR USE AND DISCLOSURE OF HEALTH INFORMATION Cybernet Medical (pdf file)
      digital.ahrq.gov/sites/default/files/docs/resource/C4_Patient_Informed_Consent_Form.pdf
      September 30, 2008 - The study addresses both direct wound treatment regimen and, if present, underlying diabetes. … If diabetes is hindering the healing of the wound, the participant may receive individualized care … If you choose not to participate in this study, the alternative treatment would be other therapeutic … If any significant new information about any of these treatments develops or any other new medical treatment … and Payments: Revised 09/21/04 Page 4 of 4 all physician or hospital costs incurred with these treatments

2073. Understanding Drivers of Health Care Disparities and Developing Targeted Interventions (pdf file)
      hcup-us.ahrq.gov/datainnovations/raceethnicitytoolkit/ca9.pdf
      June 16, 2014 - by the underlying health conditions or treatment preferences of patients. … identified > 600 studies • The IOM report identified many areas of concern: - Cardiovascular treatments … and cerebrovascular disease - HIV disease (HAART and PCP prophylaxis) - Diabetes - ESRD - Maternal … ) - Treatment of chest pain (Johnson et al. … General Internal Medicine (2008) 169 Primary Care Clinicians  88% acknowledged that disparities in diabetes

2074. Microsoft Word - 2011_04.docx (pdf file)
      hcup-us.ahrq.gov/reports/methods/2011_04.pdf
      January 01, 2011 - acute and long-term care units, operating room, radiology department, laboratories, various therapies … Radioisotope 53 electrocardiology 54 electroencenphalography 8 Laboratory LAB 44 9 Therapies … Day Program LTC 094x: Other Therapeutic Services THER 095x: Other Therapeutic Services THER 096x: … 42x THER CHG33 Occupational Therapy 43x THER CHG34 Speech Therapy 44x THER CHG35 Emergency Room … PROC W/O CC/MCC 637 46818 0.9175 0.9388 0.97726 DIABETES W MCC 638 82371 0.6163 0.6224 0.9903 DIABETES

2075. Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/B73a4kJhxeaYyXK6gozbbY
      May 24, 2022 - outcomes Reporting bias not detected Moderate for benefit VEGF inhibitors are considered first-line therapy … detected Moderate for no harm VEGF inhibitors vs sham: VEGF inhibitors are considered first-line therapy … Morphology and visual acuity in aflibercept and ranibizumab therapy for neovascular age-related macular … Oral zinc-therapy in age-related macular degeneration: a double blind study. … Introducing anti-vascular endothelial growth factor therapies for AMD did not raise risk of myocardial

2076. Archived: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/abdominal-aortic-aneurysm-screening-2014
      June 23, 2014 - Factors associated with a reduced risk for AAA include African American race, Hispanic ethnicity, and diabetes … Treatment Patients with large AAAs (≥5.5 cm) are referred for open surgical repair or endovascular … Short-term treatment with antibiotics or β-blockers does not appear to reduce AAA growth. … Factors associated with a reduced risk for AAA include African American race, Hispanic ethnicity, and diabetes … Appropriately powered studies that can assess health outcomes should evaluate whether such treatments

2077. Context-Aware Knowledge Delivery into Electronic Health Records - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/publication/k01hs018352-del-fiol-final-report-2013.pdf
      January 01, 2013 - 1% 4% 6% 1% 2% 4% How should I manage condition x (not specifying diagnostic or therapeutic)? … The most frequent factors were related to treatment decisions, specifically treatment choice (18; 26% … How tightly should we control this patient’s diabetes? … What is the best treatment choice for diabetes when the patient also has heart failure? … The knowledge summary can be narrowed to a particular treatment option by clicking on one of the treatment

2078. Population Denominator Data Sources and Data for Use with HCUP Databases (Updated with 2021 Population Data) (pdf file)
      hcup-us.ahrq.gov/reports/methods/MS2022-03-PopulationReport.pdf
      December 15, 2022 - quality of health services, medical practice patterns, access to health care programs, and outcomes of treatment … national, regional, state, county, and ZIP Code o Diseases and health statistics – health status, diabetes … The rate for the adult admissions for diabetes in the US per 100,000 U.S. population, age 18 and above … Create a 0/1 variable named DIABETES in which the value 1 indicates adult discharges with a diagnosis … of diabetes and the value 0 is used for all other discharges.

2079. MS-2020-02 (pdf file)
      hcup-us.ahrq.gov/reports/methods/2020-02.pdf
      January 01, 2020 - quality of health services, medical practice patterns, access to health care programs, and outcomes of treatment … national, regional, state, county, and ZIP Code o Diseases and health statistics – health status, diabetes … The rate for the adult admissions for diabetes in the US per 100,000 U.S. population, age 18 and above … Create a 0/1 variable named DIABETES in which the value 1 indicates adult discharges with a diagnosis … of diabetes and the value 0 is used for all other discharges.

2080. CDS Connect Implementation Guide Draft (doc file)
      cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
      October 01, 2017 - CDS Connect Implementation Guide Draft Implementation Guide Statin Therapy for the Prevention and Treatment … Implementation Guide: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease (CVD) … Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality … Figure 1: Artifact Relationship Diagram Testing The Statin Therapy for the Prevention and Treatment … CQL Q&As on the eCQI Resource Center Statin Therapy for the Prevention and Treatment of Cardiovascular